Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit

Research output: Contribution to journalLetterResearchpeer-review

Standard

Measurement of plasma glucagon in humans : A shift in the performance of a current commercially available radioimmunoassay kit. / Wu, Tongzhi; Rayner, Christopher K.; Jones, Karen L.; Horowitz, Michael; Feinle-Bisset, Christine; Standfield, Scott D.; Xie, Cong; Deacon, Carolyn F.; Holst, Jens J.; Wewer Albrechtsen, Nicolai J.

In: Diabetes, Obesity and Metabolism, Vol. 24, No. 6, 2022, p. 1182-1184.

Research output: Contribution to journalLetterResearchpeer-review

Harvard

Wu, T, Rayner, CK, Jones, KL, Horowitz, M, Feinle-Bisset, C, Standfield, SD, Xie, C, Deacon, CF, Holst, JJ & Wewer Albrechtsen, NJ 2022, 'Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit', Diabetes, Obesity and Metabolism, vol. 24, no. 6, pp. 1182-1184. https://doi.org/10.1111/dom.14673

APA

Wu, T., Rayner, C. K., Jones, K. L., Horowitz, M., Feinle-Bisset, C., Standfield, S. D., Xie, C., Deacon, C. F., Holst, J. J., & Wewer Albrechtsen, N. J. (2022). Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit. Diabetes, Obesity and Metabolism, 24(6), 1182-1184. https://doi.org/10.1111/dom.14673

Vancouver

Wu T, Rayner CK, Jones KL, Horowitz M, Feinle-Bisset C, Standfield SD et al. Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit. Diabetes, Obesity and Metabolism. 2022;24(6):1182-1184. https://doi.org/10.1111/dom.14673

Author

Wu, Tongzhi ; Rayner, Christopher K. ; Jones, Karen L. ; Horowitz, Michael ; Feinle-Bisset, Christine ; Standfield, Scott D. ; Xie, Cong ; Deacon, Carolyn F. ; Holst, Jens J. ; Wewer Albrechtsen, Nicolai J. / Measurement of plasma glucagon in humans : A shift in the performance of a current commercially available radioimmunoassay kit. In: Diabetes, Obesity and Metabolism. 2022 ; Vol. 24, No. 6. pp. 1182-1184.

Bibtex

@article{8a46c597ed654a558726fdd4443d1ef7,
title = "Measurement of plasma glucagon in humans: A shift in the performance of a current commercially available radioimmunoassay kit",
author = "Tongzhi Wu and Rayner, {Christopher K.} and Jones, {Karen L.} and Michael Horowitz and Christine Feinle-Bisset and Standfield, {Scott D.} and Cong Xie and Deacon, {Carolyn F.} and Holst, {Jens J.} and {Wewer Albrechtsen}, {Nicolai J.}",
year = "2022",
doi = "10.1111/dom.14673",
language = "English",
volume = "24",
pages = "1182--1184",
journal = "Diabetes, Obesity and Metabolism",
issn = "1462-8902",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - Measurement of plasma glucagon in humans

T2 - A shift in the performance of a current commercially available radioimmunoassay kit

AU - Wu, Tongzhi

AU - Rayner, Christopher K.

AU - Jones, Karen L.

AU - Horowitz, Michael

AU - Feinle-Bisset, Christine

AU - Standfield, Scott D.

AU - Xie, Cong

AU - Deacon, Carolyn F.

AU - Holst, Jens J.

AU - Wewer Albrechtsen, Nicolai J.

PY - 2022

Y1 - 2022

U2 - 10.1111/dom.14673

DO - 10.1111/dom.14673

M3 - Letter

C2 - 35188324

VL - 24

SP - 1182

EP - 1184

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

SN - 1462-8902

IS - 6

ER -

ID: 300908367